1. HBW Insight
  2. >>Health

US FDA's Consumer Health Oversight Absent From Appropriators’ Request For COVID-19 Assessment

At 90 And Counting, Will Supplement Warnings Merit Mention In Response?

 
• By Malcolm Spicer

House appropriators don’t mention the consumer health market in requesting a report on FDA’s response to COVID-19, but the agency’s frequent warnings about products marketed with unlawful claims could merit mentioning. Encouraging accelerated production of hand sanitizers while also ensuring the additional supplies are safe is another component of its COVID-19 response that could be covered in an assessment of its response to the pandemic.

Test result of a Corona test. Hand turns a dice and changes the expression "positive COVID19" to "negative COVID19".

US House appropriators don’t mention the consumer health market in requesting a report on the Food and Drug Administration’s response to the COVID-19 pandemic, but the agency’s frequent warnings about products marketed with unlawful claims could merit mentioning in its report.

Encouraging accelerated product of hand sanitizers while also ensuring the additional supplies are safe is another component of its COVID-19...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legislation

More from Policy & Regulation

FDA Takes World Tour In Recent OTC Warnings

 
• By Malcolm Spicer

FDA Center for Drug Evaluation and Research Office of Manufacturing Quality, Office of Compliance and Office of Unapproved Drugs & Labeling Compliance recently advise Indian, Canadian and US firms about GMP problems.

German Associations Call For EU Green Claims Directive Trilogue Suspension

 
• By David Ridley

Pharma Deutschland is one of 21 German associations calling for trilogue negotiations in relation to the EU Green Claims Directive to be suspended while a “comprehensive and independent written impact assessment” is undertaken.

Over The Counter: EU Omnibus And ESG, What You Need To Know, With CEN Group’s Jasper Crone

 
• By David Ridley

HBW Insight catches up with sustainability expert Jasper Crone to find out what consumer health companies need to know about the European Commission's Omnibus simplification package.